Trials / Completed
CompletedNCT05995561
HERA FIb Registry for Patients With Atrial Fibrillation
Heidelberg Registry of Atrial Fibrillation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12,297 (actual)
- Sponsor
- University Hospital Heidelberg · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The single-center HERA AFIb registry was created to assess real-world prevalence, demographic characteristics and management of patients with atrial fibrillation (AF) in the era of novel oral anticoagulant regimes (NOAC) presenting in the emergency department (ED) of University of Heidelberg
Detailed description
HERA AFIb is a single-center retrospective registry which enrolled consecutive cases presenting with atrial fibrillation at the emergency department of University Hospital of Heidelberg. Clinical parameters and characteristics for cases were assessed retrospectively. Follow-up was performed via review of medical reports, phone calls and postal queries. Outcome parameters included rates for all-cause mortality, non-hemorrhagic stroke, myocardial infarction and major bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | no intervention is planned. | no intervention is planned. |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2020-04-01
- Completion
- 2020-04-01
- First posted
- 2023-08-16
- Last updated
- 2024-05-09
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05995561. Inclusion in this directory is not an endorsement.